LifeStance Health Group (LFST) Stock: Buy, Sell, or Hold?
LFST - LifeStance Health Group, Inc. Common Stock
$12.33
0.11 (0.90%)
▲
5d:
-1.52%
30d:
-1.75%
90d:
+14.06%
BUY
MODERATE Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Nov 05, 2026
13d
Get Alerted When LFST Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: LFST shows positive signals but monitor for confirmation. Market pricing in 6.5% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: LFST shows positive signals but monitor for confirmation. Market pricing in 6.5% annual growth which appears achievable. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$17.80
Based on 11.9% avg growth
INTRINSIC VALUE TODAY
$11.05
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 23.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: LFST is currently trading at $12.33, which is considered fair relative to its 30-day fair value range of $11.87 to $12.67. From a valuation perspective, the stock is trading at a premium (Forward PE: 28.6) compared to its historical average (23.7). At these levels, the market is pricing in 6.5% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, LFST is in a strong uptrend. The price is approaching resistance at $12.68. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: LFST scores 63/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $14.40 (+16.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, LFST is in a strong uptrend. The price is approaching resistance at $12.68. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: LFST scores 63/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $14.40 (+16.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$11.87 -
$12.67
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
81.0%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (63/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($14.40)
- NEUTRAL: PE elevated vs history but 6.5% growth expectation is conservative given 1928% recent growth
- BULLISH: Bottoming setup score 63/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$11.87 -
$12.67
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$11.68
Resistance Level
$12.68
Current Trend
Strong Uptrend
Technical data as of
Oct 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
28.62
Wall Street Target
$14.40
(+16.8%)
Revenue Growth (YoY)
26.1%
Earnings Growth (YoY)
1927.5%
Profit Margin
3.2%
Valuation Premium vs History
+6.5% premium
PE vs Historical
28.6 vs 23.7
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+6.5%
(market-implied from PE analysis)
1-Year Target
$13.13
(+7%)
2-Year Target
$13.98
(+13%)
3-Year Target
$14.89
(+21%)
3-Yr Target (if PE normalizes)
(PE: 29→24)
PE COMPRESSION
$12.33
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 28.6, Growth: 19.8%)
$21.22
(+72%)
Base:
(SPY PE: 19.9, Growth: 19.8%)
$14.72
(+19%)
Bear:
(PE: 16.9, Growth: 19.8%)
$12.51
(+2%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (53x PE), but valuation improves significantly next year (29x PE) as earnings recover.
Forward PE: 52.63 | Forward EPS (Implied): $0.23
Bull Case
$14.89
(+21%)
Analyst growth 15.0%, PE expands to 55.3
Base Case
$12.33
(0%)
Market implied 0.0%, PE stable at 52.6
Bear Case
$9.43
(-24%)
Severe decline -15.0%, PE contracts to 47.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: October 22, 2026 5:20 AM ET
Data refreshes hourly during market hours. Next update: 6:20 AM
Data refreshes hourly during market hours. Next update: 6:20 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LFST showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
23 analysts |
$286 | 56 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
16 analysts |
$24 | 60 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
26 analysts |
$461 | 42 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
13 analysts |
$148 | 59 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
14 analysts |
$134 | 56 HOLD |
